Development and validation of a Rapid Stability Indicating chromatographic determination of Cilnidipine in Bulk and Dosage form.

M Safhi, MY Nagaraj - Research Journal of Pharmacy and …, 2013 - indianjournals.com
A rapid, simple and specific reversed-phase HPLC method has been developed for
estimation of Cilnidipine in Pharmaceutical Formulation. HPLC analysis was performed on a …

Process for the preparation of lercanidipine

BP Reddy, KR Reddy, RR Reddy, DM Reddy… - US Patent …, 2010 - Google Patents
The invention provides a novel process for the preparation of lercanidipine or a
pharmaceutical acceptable salt using novel intermediates. Thus, 2, N-dimethyl-N-(3, 3 …

Development and validation of stability indicating RP-HPLC method for estimation of Cilnidipine

B Tiwari, MK Shirsat, A Kulkarni - Journal of Drug Delivery and …, 2020 - jddtonline.info
Cilnidipine is one of the dihydropyridine calcium antagonists. It was created combinedly by
Fuji Viscera Pharmaceutical Company, Ajinomoto and Japan and was approved in the year …

[引用][C] 乐卡地平

孙忠实, 朱珠 - 中国新药杂志, 2001 - cqvip.com
[通用名称] lercanidipine, 乐卡地平[别名] Masnidipine [商品名称] Lerdip, Zanidip [化学名称](±)-
2-[(3, 3)-二苯丙基] 甲氨基-1, 1-二甲乙基1, 4-二羟基-2, 6-二甲基-4-(间-硝基苯基)-3, 5 …

[HTML][HTML] The fourth-generation Calcium channel blocker: Cilnidipine

KS Chandra, G Ramesh - Indian heart journal, 2013 - Elsevier
Several classes of antihypertensive agents have been in clinical use, including diuretics, α-
blockers, β-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin II type 1 …

[PDF][PDF] Development and validation of novel UV and RP-HPLC methods for determination of cilnidipine (a new generation ca channel blocker) in pharmaceutical …

PR Sankar, V Swathi, PS Babu - International Journal of …, 2019 - academia.edu
An accurate and precise High-Performance Reversed-Phase Liquid Chromatographic and
UV spectrophotometric methods were developed and validated for the quantitative …

Crude and crystalline forms of lercanidipine hydrochloride

F Bonifacio, F Campana, G De Iasi… - US Patent 6,852,737, 2005 - Google Patents
(56) References Cited(57) ABSTRACT US PATENT DOCUMENTS The invention describes
novel lercanidipine crude Forms 4,285,955 A 8/1981 Wehinger et al.(A) and (B), novel …

An Investigative Review for Pharmaceutical Analysis of 1, 4-Dihydropyridine-3, 5-Dicarboxylic Acid Derivative: Cilnidipine

SR Chaudhari, AA Shirkhedkar - Critical reviews in analytical …, 2021 - Taylor & Francis
Hypertension is commonly a quiet condition, and it expands the risk of heart diseases and
stroke. Calcium delivers a substantial role in cardiovascular functions and hence is essential …

STABILITY-INDICATING REVERSED-PHASE HPLC METHOD FOR THE SEPARATION AND ESTIMATION OF RELATED IMPURITIES OF CILNIDIPINE IN …

BB Kasimala, VR Anna, UR Mallu - Indian Drugs, 2018 - search.ebscohost.com
A novel HPLC method was developed and validated for the determination of cilnidipine
(CLDP) along with its related impurities A and B in pharmaceutical formulations. The …

Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof

MS Sawant, MM Biswas, MA Khan, S Sinha… - US Patent …, 2012 - Google Patents
Processes for the purification of lercanidipine hydrochloride are provided which uses a
binary system of an alcohol-containing solvent such as methanol and an aliphatic ester …